[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

Otsuka et al., 2011 - Google Patents

Application of principal component analysis enables to effectively find important physical variables for optimization of fluid bed granulator conditions

Otsuka et al., 2011

Document ID
9389638022259750683
Author
Otsuka T
Iwao Y
Miyagishima A
Itai S
Publication year
Publication venue
International journal of pharmaceutics

External Links

Snippet

Principal component analysis was applied to effectively optimize the operational conditions of a fluidized bed granulator for preparing granules with excellent compaction and tablet physical properties. The crucial variables that affect the properties of the granules, their …
Continue reading at www.sciencedirect.com (other versions)

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N15/00—Investigating characteristics of particles; Investigating permeability, pore-volume, or surface-area of porous materials
    • G01N15/02—Investigating particle size or size distribution
    • G01N15/0205—Investigating particle size or size distribution by optical means, e.g. by light scattering, diffraction, holography or imaging
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/483—Physical analysis of biological material
    • G01N33/487—Physical analysis of biological material of liquid biological material

Similar Documents

Publication Publication Date Title
Otsuka et al. Application of principal component analysis enables to effectively find important physical variables for optimization of fluid bed granulator conditions
Saker et al. Powders flowability assessment in granular compaction: What about the consistency of Hausner ratio?
Dai et al. A compression behavior classification system of pharmaceutical powders for accelerating direct compression tablet formulation design
Hlinak et al. Understanding critical material properties for solid dosage form design
Hou et al. Quantifying effects of particulate properties on powder flow properties using a ring shear tester
Mullarney et al. The powder flow and compact mechanical properties of sucrose and three high-intensity sweeteners used in chewable tablets
Tan et al. On the methods to measure powder flow
Bodhmage Correlation between physical properties and flowability indicators for fine powders
Huang et al. Improving blend content uniformity via dry particle coating of micronized drug powders
Megarry et al. A big data approach to pharmaceutical flow properties
Fang et al. Classification of microcrystalline celluloses via structures of individual particles measured by synchrotron radiation X-ray micro-computed tomography
Barot et al. Compactibility improvement of metformin hydrochloride by crystallization technique
Mangwandi et al. Effect of batch size on mechanical properties of granules in high shear granulation
Li et al. Application of the central composite design to optimize the calcium carbonate-HPMC co-processed excipient prepared by co-spray drying
Zhao et al. A new parameter for characterization of tablet friability based on a systematical study of five excipients
Anzilaggo et al. Liquisolid systems: Understanding the impact of drug state (solution or dispersion), nonvolatile solvent and coating material on simvastatin apparent aqueous solubility and flowability
Santitewagun et al. Detecting crystallinity using terahertz spectroscopy in 3D printed amorphous solid dispersions
Salehi et al. Understanding flow properties of mannitol powder at a range of temperature and humidity
Virtanen et al. Granule size distribution of tablets
Gaikwad et al. An overview of the implementation of SeDeM and SSCD in various formulation developments
Peeters et al. Evaluation of the influence of material properties and process parameters on granule porosity in twin-screw wet granulation
Ghazi et al. Investigating the effect of APAP crystals on tablet behavior manufactured by direct compression
Vidovič et al. Elucidating molecular properties of kappa-carrageenan as critical material attributes contributing to drug dissolution from pellets with a multivariate approach
Sidwell et al. Characterization of inert cores for multiparticulate dosage forms
FUENTES-GONZÁLEZ et al. POWDER FLOWABILITY AS A FUNCTIONALITY PARAMETER OF THE EXCIPIENT GALENIQ